FX.co ★ Biotech Year In Review: SGMO Up 700%, CORT Surges 400%, AUPH & JANX Double

Richard Branson famously noted, "Every risk is worth taking as long as it's for a good cause and contributes to a good life." Trading, by its very nature, involves risk. However, with an effective strategy and well-timed decisions, it can yield substantial returns in a relatively short period. Highlighted here are several biotech stocks that have delivered notable gains this year, as featured on our platform. For a comprehensive list, we invite you to visit FXco Biotech Investor.